SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

iShares Neuroscience and Healthcare ETF (IBRN) News

Follow iShares Neuroscience and Healthcare ETF (IBRN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol IBRN Asset equity Sector Markets 90 days 0 Last 32.95 Updated Aug 13, 2026, 04:28 PM UTC Open live news feed Open IBRN chart & news
M PTC Therapeutics plans ST-920 Fabry program acquisition PTC Therapeutics says it will acquire Sangamo Therapeutics’ ST-920 Fabry disease program in a competitive bankruptcy auction for $111 million upfront plus up to $100 million in contingent milestone payments. MNA | Aug 13, 2026, 04:28 PM UTC